Faculty & Research
Overview
Faculty & research are integral components of BME. With a strong focus on research, BME is located in the heart of Canada’s largest health-care research hub. Our graduate students receive their training from 14 departments at U of T, 10 partner hospitals, and 7 research institutes & commercialization centres.
At BME, our cross-disciplinary approach in biomedical and clinical engineering enables our researchers to cover a diverse set of topics. Find out what our research publication are saying about our research focus.
Faculty directory
Core Faculty
We have 30+ core faculty members that span across cell & tissue engineering, clinical engineering, and molecular engineering disciplines.
Cross-Appointed Faculty
BME currently hosts cross-appointed faculty members across more than 30 academic units, partner hospitals, research institutes, and commercialization centres.
Emeriti
Learn about some of our retired faculty members
Research streams
Clinical
BME’s clinical engineers design technologies, devices and strategies for people with chronic disease, traumatic injury, disabilities and mobility limitations to help them integrate more fully with their environment.
Cell & Tissue
Research that has the potential to change how we think about disease and aging is happening at BME. Regenerative medicine uses stem cells and biomaterials to repair, replace or regenerate damaged tissue, organ structures and function.
Molecular
BME researchers are advancing disease detection, customizing drug delivery and improving health-care outcomes with faster and more precise technologies and systems.
Latest news
New technique improves measurement of cell barriers
Researchers at the University of Toronto have developed a novel, cost-effective method called Porous Membrane Electrical Cell–Substrate Impedance Spectroscopy (PM-ECIS) to assess the function of biological barriers in Petri dishes. In a subsequent study, the researchers characterized its sensitivity and further validated the method against a gold-standard barrier assessment technique. This new method could enhance research in fields like drug development and disease modeling.
Immune cells pave the way for advanced Heart-on-a-Chip Technology
Researchers at the University of Toronto have made strides in heart disease research by incorporating primitive macrophages—a crucial immune cell—into heart-on-a-chip technology. This innovative approach promises to enhance the functionality and stability of engineered heart tissues, potentially transforming drug testing and disease modeling.
Professor Alison McGuigan awarded Senior Scientist Award at 7th TERMIS World Congress
Professor Alison McGuigan has been honored with the prestigious Tissue Engineering and Regenerative Medicine International Society Americas Chapters (TERMIS-AM) Senior Scientist Award. This esteemed award was presented to Professor McGuigan on the final day of the 7th TERMIS World Congress Conference, held from June 25-28 in Seattle, Washington. The Senior Scientist Award is conferred upon individuals who have made significant contributions to the fields of tissue engineering and regenerative medicine.
Molly Shoichet named inaugural Pamela and Paul Austin Chair in Precision and Regenerative Medicine
University Professor Molly Shoichet (ChemE, BME) has been named the inaugural Pamela and Paul Austin Chair in Precision and Regenerative Medicine. The chair, situated within the Department of Chemical Engineering & Applied Chemistry, was created in November 2023 via a gift from the The P. Austin Family Foundation.
Functional Electrical Stimulation sleeve to improve rehabilitation for motor control impairments
A recent study published in BioMedical Engineering OnLine introduces a novel smart sleeve designed for Functional Electrical Stimulation (FES) applications. This new technology integrates advanced carbon-based dry electrodes within a textile structure, offering significant improvements in comfort and usability for patients with motor control impairments.
Faculty startups
The following list highlights some of the startup companies that have been launched by these forward-thinking faculty members, demonstrating their commitment to translating academic knowledge into real-world applications and making a significant impact on the biomedical industry.
Faculty Member | Commercialization Venture | Focus | Location |
---|---|---|---|
Jan Andrysek | LegWorks | Prosthetic Knee Joint | San Francisco |
Warren Chan | Luna Nanotech | Nanotechnology Product Supplier | Toronto |
John E. Davies | Tissue Regenerative Therapeutics Inc. | Mesenchymal Stem Cells | Toronto |
Milos Popovich | MyndTech Inc. | Medical Tech Company | Mississauga |
Milica Radisic | Tara Biosystems | Cardiac Drug Discovery | New York |
Jonathan Rocheleau | QuantM3 | Microfluidics Technology Diabetes Treatment | Toronto |
Paul Santerre | Interface Biologics | Drug Delivery and other technologies | Toronto |
Paul Santerre and Eli Sone | Cohesys Inc | Bone Tape to replace plate and screws in craniofacial repair; Angel investment | Toronto |
Paul Santerre | Ripple Therapeutics | Non-polymeric anti-inflammatory drug delivery systems for ophthalmology; venture invested | Toronto |
Molly Shoichet | AmacaThera | Injectable hydrogel platform technology | Toronto |
Aaron Wheeler | Miroculus (formerly Kappex) | Digital Microfluidics Platform | Toronto |